Upgrade to SI Premium - Free Trial

Myomo (MYO) Reports Publication of Significant Clinical Research

June 27, 2017 11:55 AM
Myomo, Inc. (NYSE MKT: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today announced publication of an ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News FDA Management Comments Momentum Movers

Next Articles